| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant active specific immunotherapy of stage II and stage III colon cancer with an autologous tumor cell vaccine: first randomized phase III trials show promise
|
Hanna Jr., Michael G.
|
|
2001
|
19 |
17-19 |
p. 2576-2582
7 p.
|
artikel
|
| 2 |
Adjuvants designed for veterinary and human vaccines
|
Aucouturier, J.
|
|
2001
|
19 |
17-19 |
p. 2666-2672
7 p.
|
artikel
|
| 3 |
Adverse events and vaccination-the lack of power and predictability of infrequent events in pre-licensure study
|
Jacobson, Robert M.
|
|
2001
|
19 |
17-19 |
p. 2428-2433
6 p.
|
artikel
|
| 4 |
An efficacious recombinant subunit vaccine against the salmonid rickettsial pathogen Piscirickettsia salmonis
|
Kuzyk, Michael A.
|
|
2001
|
19 |
17-19 |
p. 2337-2344
8 p.
|
artikel
|
| 5 |
An in vitro approach in quality control of toxoid vaccines
|
Leenaars, P.P.A.M
|
|
2001
|
19 |
17-19 |
p. 2729-2733
5 p.
|
artikel
|
| 6 |
Announcement-3rd World Congress on Vacc
|
|
|
2001
|
19 |
17-19 |
p. I-
1 p.
|
artikel
|
| 7 |
Announcement-World Vaccine Congress
|
|
|
2001
|
19 |
17-19 |
p. 2762-
1 p.
|
artikel
|
| 8 |
A powder formulation of measles vaccine for aerosol delivery
|
LiCalsi, Cynthia
|
|
2001
|
19 |
17-19 |
p. 2629-2636
8 p.
|
artikel
|
| 9 |
A prophylactic hepatitis B vaccine with a novel adjuvant system
|
Thoelen, Stefaan
|
|
2001
|
19 |
17-19 |
p. 2400-2403
4 p.
|
artikel
|
| 10 |
A therapeutic vaccine for mucosal candidiasis
|
Elahi, Shokrollah
|
|
2001
|
19 |
17-19 |
p. 2516-2521
6 p.
|
artikel
|
| 11 |
Australian experience in general medical practice immunization — achievements and problems
|
Downs, David
|
|
2001
|
19 |
17-19 |
p. 2413-2417
5 p.
|
artikel
|
| 12 |
Autologous, hapten-modified vaccine as a treatment for human cancers
|
Berd, David
|
|
2001
|
19 |
17-19 |
p. 2565-2570
6 p.
|
artikel
|
| 13 |
Characterisation of a protective linear B cell epitope against feline parvoviruses
|
Langeveld, Jan P.M.
|
|
2001
|
19 |
17-19 |
p. 2352-2360
9 p.
|
artikel
|
| 14 |
Clinical relevance of lower Hib response in DTPa-based combination vaccines
|
Poolman, Jan
|
|
2001
|
19 |
17-19 |
p. 2280-2285
6 p.
|
artikel
|
| 15 |
Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer
|
Adams, M.
|
|
2001
|
19 |
17-19 |
p. 2549-2556
8 p.
|
artikel
|
| 16 |
Combining hepatitis A and B vaccination in children and adolescents
|
Van Damme, Pierre
|
|
2001
|
19 |
17-19 |
p. 2407-2412
6 p.
|
artikel
|
| 17 |
Conjugates and reverse vaccinology to eliminate bacterial meningitis
|
Rappuoli, Rino
|
|
2001
|
19 |
17-19 |
p. 2319-2322
4 p.
|
artikel
|
| 18 |
Current progress in the development of human immunodeficiency virus vaccines: research and clinical trials
|
Klein, Michel
|
|
2001
|
19 |
17-19 |
p. 2210-2215
6 p.
|
artikel
|
| 19 |
DNA vaccination against respiratory influenza virus infection
|
Wong, Jonathan P.
|
|
2001
|
19 |
17-19 |
p. 2461-2467
7 p.
|
artikel
|
| 20 |
Evaluation of genetic vaccine against classical swine fever
|
Markowska-Daniel, Iwona
|
|
2001
|
19 |
17-19 |
p. 2480-2484
5 p.
|
artikel
|
| 21 |
Expansion of HBV-specific memory CTL primed by dual HIV/HBV genetic immunization during SHIV primary infection in rhesus macaques
|
Borgne, Sylvie Le
|
|
2001
|
19 |
17-19 |
p. 2485-2495
11 p.
|
artikel
|
| 22 |
Exploiting molecular mimicry to broaden the immune response to carbohydrate antigens for vaccine development
|
Cunto-Amesty, Gina
|
|
2001
|
19 |
17-19 |
p. 2361-2368
8 p.
|
artikel
|
| 23 |
Generation of auto-antibodies towards Alzheimer's disease vaccination
|
Frenkel, D.
|
|
2001
|
19 |
17-19 |
p. 2615-2619
5 p.
|
artikel
|
| 24 |
Genetic adjuvants for DNA vaccines
|
Scheerlinck, Jean-Pierre Y
|
|
2001
|
19 |
17-19 |
p. 2647-2656
10 p.
|
artikel
|
| 25 |
Genomic tools for gene and protein discovery in malaria: toward new vaccines
|
Carucci, Daniel J.
|
|
2001
|
19 |
17-19 |
p. 2315-2318
4 p.
|
artikel
|
| 26 |
Gram-positive and Gram-negative bacteria as carrier systems for DNA vaccines
|
Dietrich, Guido
|
|
2001
|
19 |
17-19 |
p. 2506-2512
7 p.
|
artikel
|
| 27 |
Heat shock proteins: the ‘Swiss Army Knife’ vaccines against cancers and infectious agents
|
Srivastava, Pramod K.
|
|
2001
|
19 |
17-19 |
p. 2590-2597
8 p.
|
artikel
|
| 28 |
Hepatitis B: vaccination programmes in Europe — an update
|
Van Damme, Pierre
|
|
2001
|
19 |
17-19 |
p. 2375-2379
5 p.
|
artikel
|
| 29 |
Herd immunity after vaccination: how to quantify it and how to use it to halt disease
|
De Jong, Mart C.M.
|
|
2001
|
19 |
17-19 |
p. 2722-2728
7 p.
|
artikel
|
| 30 |
Identification and characterisation of multiple linear B cell protectopes in the respiratory syncytial virus G protein
|
Power, Ultan F.
|
|
2001
|
19 |
17-19 |
p. 2345-2351
7 p.
|
artikel
|
| 31 |
Immune responses to ISCOM® formulations in animal and primate models
|
Sjölander, Anders
|
|
2001
|
19 |
17-19 |
p. 2661-2665
5 p.
|
artikel
|
| 32 |
Immunization of livestock with DNA vaccines: current studies and future prospects
|
van Drunen Littel-van den Hurk, S.
|
|
2001
|
19 |
17-19 |
p. 2474-2479
6 p.
|
artikel
|
| 33 |
Immunoprophylactic strategies against respiratory influenza virus infection
|
Saravolac, Edward G
|
|
2001
|
19 |
17-19 |
p. 2227-2232
6 p.
|
artikel
|
| 34 |
Immunotherapy of chronic hepatitis B by anti HBV vaccine: from present to future
|
Michel, M.-L.
|
|
2001
|
19 |
17-19 |
p. 2395-2399
5 p.
|
artikel
|
| 35 |
Inactivated poliovirus vaccine and the final stages of poliovirus eradication
|
Hovi, Tapani
|
|
2001
|
19 |
17-19 |
p. 2268-2272
5 p.
|
artikel
|
| 36 |
Influenza vaccines: a review and rationale for use in developed and underdeveloped countries
|
Poland, Gregory A.
|
|
2001
|
19 |
17-19 |
p. 2216-2220
5 p.
|
artikel
|
| 37 |
Making vaccines more acceptable — methods to prevent and minimize pain and other common adverse events associated with vaccines
|
Jacobson, Robert M
|
|
2001
|
19 |
17-19 |
p. 2418-2427
10 p.
|
artikel
|
| 38 |
Measles elimination: old and new challenges?
|
Muller, Claude P.
|
|
2001
|
19 |
17-19 |
p. 2258-2261
4 p.
|
artikel
|
| 39 |
Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL-2, IFN-γ, or IL-4 gene adjuvants
|
Kim, J.Joseph
|
|
2001
|
19 |
17-19 |
p. 2496-2505
10 p.
|
artikel
|
| 40 |
Monitoring of measles elimination using molecular epidemiology
|
Mulders, Mick N.
|
|
2001
|
19 |
17-19 |
p. 2245-2249
5 p.
|
artikel
|
| 41 |
Mucosal immunity in the lung and upper airway
|
Kyd, Jennelle M.
|
|
2001
|
19 |
17-19 |
p. 2527-2533
7 p.
|
artikel
|
| 42 |
Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants
|
Pizza, M.
|
|
2001
|
19 |
17-19 |
p. 2534-2541
8 p.
|
artikel
|
| 43 |
New strategies for closing the gap of measles susceptibility in infants: towards vaccines compatible with current vaccination schedules
|
El Kasmi, Karim C.
|
|
2001
|
19 |
17-19 |
p. 2238-2244
7 p.
|
artikel
|
| 44 |
Oral immunisation of naive and primed animals with transgenic potato tubers expressing LT-B
|
Lauterslager, T.G.M
|
|
2001
|
19 |
17-19 |
p. 2749-2755
7 p.
|
artikel
|
| 45 |
Oral poliomyelitis vaccine: time to change?
|
Swennen, B
|
|
2001
|
19 |
17-19 |
p. 2262-2267
6 p.
|
artikel
|
| 46 |
Peptide and recombinant antigens for protection against bacterial middle ear infection
|
Bakaletz, Lauren O.
|
|
2001
|
19 |
17-19 |
p. 2323-2328
6 p.
|
artikel
|
| 47 |
Pitfalls of reductionism in the design of peptide-based vaccines
|
Van Regenmortel, M.H.V.
|
|
2001
|
19 |
17-19 |
p. 2369-2374
6 p.
|
artikel
|
| 48 |
Plant-based vaccines: unique advantages
|
Streatfield, Stephen J.
|
|
2001
|
19 |
17-19 |
p. 2742-2748
7 p.
|
artikel
|
| 49 |
Pneumococcal infection and vaccination in the elderly
|
Vlasich, Clemens
|
|
2001
|
19 |
17-19 |
p. 2233-2237
5 p.
|
artikel
|
| 50 |
Post-exposure DNA vaccination protects mice against rabies virus
|
Lodmell, Donald L
|
|
2001
|
19 |
17-19 |
p. 2468-2473
6 p.
|
artikel
|
| 51 |
Preface
|
Kurstak, Prof.Dr.Edouard
|
|
2001
|
19 |
17-19 |
p. 2197-
1 p.
|
artikel
|
| 52 |
Prevention of measles in Sudan: a prospective study on vaccination, diagnosis and epidemiology
|
de Swart, Rik L.
|
|
2001
|
19 |
17-19 |
p. 2254-2257
4 p.
|
artikel
|
| 53 |
Production of antibodies and antibody fragments in plants
|
Peeters, Koen
|
|
2001
|
19 |
17-19 |
p. 2756-2761
6 p.
|
artikel
|
| 54 |
Programmed inflammatory processes induced by mucosal immunisation
|
Foxwell, A.Ruth
|
|
2001
|
19 |
17-19 |
p. 2522-2526
5 p.
|
artikel
|
| 55 |
Progress in vaccination against Helicobacter pylori
|
Sutton, Philip
|
|
2001
|
19 |
17-19 |
p. 2286-2290
5 p.
|
artikel
|
| 56 |
Recent progress in vaccines development and new trends in immunisation
|
Kurstak, Edouard
|
|
2001
|
19 |
17-19 |
p. 2198-2200
3 p.
|
artikel
|
| 57 |
Recombinant attenuated bacteria for the delivery of subunit vaccines
|
Gentschev, Ivaylo
|
|
2001
|
19 |
17-19 |
p. 2621-2628
8 p.
|
artikel
|
| 58 |
Recombinant measles viruses expressing heterologous antigens of mumps and simian immunodeficiency viruses
|
Wang, Z.
|
|
2001
|
19 |
17-19 |
p. 2329-2336
8 p.
|
artikel
|
| 59 |
Reverse vaccinology, a genome-based approach to vaccine development
|
Rappuoli, Rino
|
|
2001
|
19 |
17-19 |
p. 2688-2691
4 p.
|
artikel
|
| 60 |
Safety and immunogenicity of an intranasal Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers
|
Larbig, M
|
|
2001
|
19 |
17-19 |
p. 2291-2297
7 p.
|
artikel
|
| 61 |
Safety, efficacy and effectiveness of the influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children and healthy adults
|
Mendelman, Paul M
|
|
2001
|
19 |
17-19 |
p. 2221-2226
6 p.
|
artikel
|
| 62 |
Studying experimental measles virus vaccines in the presence of maternal antibodies in the cotton rat model (Sigmodon hispidus)
|
Niewiesk, Stefan
|
|
2001
|
19 |
17-19 |
p. 2250-2253
4 p.
|
artikel
|
| 63 |
Technologies for the design, discovery, formulation and administration of vaccines
|
Ellis, Ronald W
|
|
2001
|
19 |
17-19 |
p. 2681-2687
7 p.
|
artikel
|
| 64 |
The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine
|
Podda, Audino
|
|
2001
|
19 |
17-19 |
p. 2673-2680
8 p.
|
artikel
|
| 65 |
The bare skin and the nose as non-invasive routes for administering peptide vaccines
|
Partidos, Charalambos D.
|
|
2001
|
19 |
17-19 |
p. 2708-2715
8 p.
|
artikel
|
| 66 |
The B cell targeted adjuvant, CTA1-DD, exhibits potent mucosal immunoenhancing activity despite pre-existing anti-toxin immunity
|
Lycke, Nils
|
|
2001
|
19 |
17-19 |
p. 2542-2548
7 p.
|
artikel
|
| 67 |
The efficacy of oral vaccination of mice with alginate encapsulated outer membrane proteins of Pasteurella haemolytica and One-Shot®
|
Kidane, Argaw
|
|
2001
|
19 |
17-19 |
p. 2637-2646
10 p.
|
artikel
|
| 68 |
The future of vaccines, immunisation concepts and practice
|
André, Francis E.
|
|
2001
|
19 |
17-19 |
p. 2206-2209
4 p.
|
artikel
|
| 69 |
The green revolution: plants as heterologous expression vectors
|
Koprowski, H.
|
|
2001
|
19 |
17-19 |
p. 2735-2741
7 p.
|
artikel
|
| 70 |
The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines
|
Pau, M.G.
|
|
2001
|
19 |
17-19 |
p. 2716-2721
6 p.
|
artikel
|
| 71 |
The incurable wound revisited: progress in human rabies prevention?
|
Hanlon, C.A
|
|
2001
|
19 |
17-19 |
p. 2273-2279
7 p.
|
artikel
|
| 72 |
The organotypic culture of HPV-transformed keratinocytes: an effective in vitro model for the development of new immunotherapeutic approaches for mucosal (pre)neoplastic lesions
|
Delvenne, P.
|
|
2001
|
19 |
17-19 |
p. 2557-2564
8 p.
|
artikel
|
| 73 |
The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants
|
McCluskie, Michael J.
|
|
2001
|
19 |
17-19 |
p. 2657-2660
4 p.
|
artikel
|
| 74 |
The prevention of Lyme disease with vaccine
|
Poland, Gregory A.
|
|
2001
|
19 |
17-19 |
p. 2303-2308
6 p.
|
artikel
|
| 75 |
Therapeutic potential of protein and adjuvant vaccinations on tumour growth
|
Gérard, C.M
|
|
2001
|
19 |
17-19 |
p. 2583-2589
7 p.
|
artikel
|
| 76 |
Therapeutic vaccines against melanoma and colorectal cancer
|
Tartaglia, Jim
|
|
2001
|
19 |
17-19 |
p. 2571-2575
5 p.
|
artikel
|
| 77 |
The role of mass spectrometry in vaccine development
|
Poland, Gregory A.
|
|
2001
|
19 |
17-19 |
p. 2692-2700
9 p.
|
artikel
|
| 78 |
Transcutaneous immunization: T cell responses and boosting of existing immunity
|
Hammond, Scott A
|
|
2001
|
19 |
17-19 |
p. 2701-2707
7 p.
|
artikel
|
| 79 |
Transmission blocking malaria vaccines
|
Carter, Richard
|
|
2001
|
19 |
17-19 |
p. 2309-2314
6 p.
|
artikel
|
| 80 |
Tuberculosis subunit vaccine development: on the role of interferon-γ
|
Agger, E.M.
|
|
2001
|
19 |
17-19 |
p. 2298-2302
5 p.
|
artikel
|
| 81 |
Twin studies of immunogenicity — determining the genetic contribution to vaccine failure
|
Tan, Poh-Lin
|
|
2001
|
19 |
17-19 |
p. 2434-2439
6 p.
|
artikel
|
| 82 |
Understanding those who do not understand: a brief review of the anti-vaccine movement
|
Poland, Gregory A.
|
|
2001
|
19 |
17-19 |
p. 2440-2445
6 p.
|
artikel
|
| 83 |
Update on hepatitis B vaccination in Italy 10 years after its implementation
|
Zanetti, Alessandro R
|
|
2001
|
19 |
17-19 |
p. 2380-2383
4 p.
|
artikel
|
| 84 |
Using in silico transcriptomics to search for tumor-associated antigens for immunotherapy
|
Vinals, Carla
|
|
2001
|
19 |
17-19 |
p. 2607-2614
8 p.
|
artikel
|
| 85 |
Vaccination against hepatitis B in health care workers
|
Bonanni, Paolo
|
|
2001
|
19 |
17-19 |
p. 2389-2394
6 p.
|
artikel
|
| 86 |
Vaccination against hepatitis viruses in Poland
|
Slusarczyk, Janusz
|
|
2001
|
19 |
17-19 |
p. 2384-2388
5 p.
|
artikel
|
| 87 |
Vaccination policy against hepatitis A in Italy
|
Stroffolini, Tommaso
|
|
2001
|
19 |
17-19 |
p. 2404-2406
3 p.
|
artikel
|
| 88 |
Vaccination with Her-2/neu DNA or protein subunits protects against growth of a Her-2/neu-expressing murine tumor
|
Foy, Teresa M
|
|
2001
|
19 |
17-19 |
p. 2598-2606
9 p.
|
artikel
|
| 89 |
Vaccine safety — improving monitoring
|
Heijbel, Harald
|
|
2001
|
19 |
17-19 |
p. 2457-2460
4 p.
|
artikel
|
| 90 |
Vaccine safety: risk communication — a global perspective
|
Dittmann, Sieghart
|
|
2001
|
19 |
17-19 |
p. 2446-2456
11 p.
|
artikel
|
| 91 |
Vaccines and mucosal immunisation
|
Cripps, Allan W.
|
|
2001
|
19 |
17-19 |
p. 2513-2515
3 p.
|
artikel
|
| 92 |
Vaccines — a wonderful tool for equity in health
|
Jimenez, Jorge
|
|
2001
|
19 |
17-19 |
p. 2201-2205
5 p.
|
artikel
|
Tijdschrift beschrijving